Ultomiris Prescription Discount Coupon

Life happens. When it does, you may need help with your medicine or co-pay costs. Many drug manufactor provide drug coupon to help with medication.

Ultomiris Coupon Details

Ultomiris Alexion OneSource CoPay Program: Eligible commercially insured patients may pay as little as $0 in out-of-pocket costs up to a maximum savings of $15,000 per calendar year; for additional information contact the program at 888-765-4747.

Benefits :

• Prescription
• Offer Type: Copay Card Program
• Activate By: Patient
• Coverage Requirments:
• Pharmacy Support Number 888-765-4747

Contact Details :

Free Discount Drug Coupon

All patients are eligible to receive a discount by using this free Ultomiris coupon. Save up to 80% on your prescription costs when using our drug coupons at your local pharmacy.

Ultomiris Cost

How much does Ultomiris cost near you?

It may varies based on the pharmacy you fill you prescription from.

Ultomiris Copay Assistance

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines and copay programs to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Elligibility requirements:

• 1. Must be uninsured.
• 2. At or below 400% of FPL.
• 3. Must reside and receive treatment in US.
• 4. Ultomiris Copay assistance, and patient assistance programs are available for eligible patients.

Programs

What is Ultomiris

Ultomiris (ravulizumab) is a monoclonal antibody. Monoclonal antibodies are man-made antibodies that fight antigens (harmful substances) in the body.

Ultomiris injection is used to treat paroxysmal nocturnal hemoglobinuria (PNH) in adults and children who are at least 1 month old.

PNH is a rare genetic disorder in which defective red blood cells break down prematurely and leak hemoglobin into your blood. Hemoglobin is the iron-rich protein that gives blood its red color. When hemoglobin passes into your urine, it can appear dark or tea-colored (especially in the morning or after sleep, when the urine is most concentrated).

Ultomiris is also used to treat a rare chronic blood disease called hemolytic uremic syndrome (aHUS) in adults and children who are at least 1 month old. This medicine is not for use in treating HUS that is related to Shiga toxin E. coli.

Ultomiris is available only under a special program. You must be registered in the program and understand the risks and benefits of this medicine.

Warnings

Ultomiris affects your immune system. You may get infections more easily, even serious or fatal infections. Call your doctor if you have a fever, flu-like symptoms, muscle pain, headache, confusion, neck or back stiffness, vomiting, rash, or your eyes are more sensitive to light.

You will need to receive certain vaccinations before you start using Ultomiris.

Ultomiris comes with a Patient Safety Card listing symptoms of meningococcal infection. Keep this card with you at all times while using Ultomiris and for at least 8 months after your last dose. Your infection risk could last for several months after you stop using this medicine.

Some people may have an increased risk of gonorrhea (a sexually transmitted disease) while using this medicine. Talk with your doctor about safe ways to keep from getting an infection during sex.

Before taking this medicine

You should not be treated with Ultomiris if you are allergic to ravulizumab, if you have a meningococcal infection (such as meningitis or sepsis), or if you are not currently vaccinated against meningitis (unless the risks of delaying treatment outweigh the risks of developing meningitis).

You will need to receive a vaccine to protect against meningococcal infections at least 2 weeks before you start using Ultomiris. If your child is treated with this medicine, make sure he or she is vaccinated against pneumonia and influenza type B (Hib).

If you need to start receiving this medicine before you are vaccinated, you may be given antibiotic medicine to take during the first 2 weeks of Ultomiris treatment.

Tell your doctor if you have recently had any symptoms of infection (fever, chills, or flu-like symptoms).

Tell your doctor if you are pregnant. It is not known whether ravulizumab will harm an unborn baby. However, having PNH during pregnancy may cause complications in the baby or the mother, including blood clots, infections, bleeding, miscarriage, premature delivery, or death. The benefit of treating PNH may outweigh any risks to the baby or the mother.

Do not breastfeed while using Ultomiris, and for at least 8 months after your last dose.

Ultomiris is not approved for use by anyone younger than 1 month old.

How is Ultomiris given?

Use Ultomiris exactly as prescribed by your doctor. Follow all directions on your prescription label and read all medication guides or instruction sheets.

If you've been using another drug called eculizumab (Soliris), you will need to wait 2 weeks after your last dose of eculizumab before starting treatment with Ultomiris.

Ultomiris is injected into a vein by a healthcare provider. The first two infusions are usually given 2 weeks apart, followed by an infusion once every 4-8 weeks.

After each infusion, you will be watched closely for at least 1 hour to make sure you do not have an allergic reaction.

Doses are based on weight. Your dose may change if you gain or lose weight.

You may get infections more easily, even serious or fatal infections. You will need frequent medical tests.

Read the Patient Safety Card about serious infections and the symptoms to watch for. Keep this card with you at all times while using Ultomiris and for at least 8 months after your last dose. Your infection risk could last for several months after you stop using this medicine.

Some people may have an increased risk of gonorrhea (a sexually transmitted disease). Talk with your doctor about safe ways to keep from getting an infection during sex.

Ultomiris can have long lasting effects on your body, even after you stop using this medicine. If you have PNH and you stop using Ultomiris, your doctor may need to check your progress for at least 16 weeks after your last dose. If you have aHUS and you stop using Ultomiris, your doctor may need to check you for at least 12 months after your last dose.

Ultomiris Side Effects

Get emergency medical help if you have signs of an allergic reaction to Ultomiris: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Some side effects may occur during the injection. Tell your caregiver if you feel light-headed or if you have chest pain, trouble breathing, or swelling in your face.

Call your doctor right away if you have signs of infection such as:

• muscle pain with flu-like symptoms;

• fever and a rash;

• fever and a headache;

• headache and stiffness in your neck or back;

• headache and nausea or vomiting;

• confusion; or

• your eyes may be more sensitive to light.

Call your doctor at once if you have symptoms of gonorrhea, such as:

• pain or burning when you urinate;

• pain or swelling of the genital or rectal area;

• unusual vaginal bleeding; or

• foul discharge from the penis or vagina.

If you stop using Ultomiris, tell your doctor if you have any new or worsening symptoms, such as: tiredness, confusion, stomach pain, chest pain, trouble breathing or swallowing, (in men) trouble having an erection, blood in your urine, a seizure, or loss of consciousness.

Common Ultomiris side effects may include:

• fever;

• high blood pressure;

• diarrhea, nausea, vomiting;

• headache; or

• cold symptoms such as stuffy nose, sneezing, sore throat.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Free Discount Drug Coupon

All patients are eligible to receive a discount by using this free Ultomiris coupon. Save up to 80% on your prescription costs when using our drug coupons at your local pharmacy.